This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Frontotemporal dementia, wide, incl. Pick's disease
FTD_WIDE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
218 |
4. Check minimum number of eventsNone |
218 |
5. Include endpointsNone |
218 |
6. Filter based on genotype QC (FinnGen only) |
218 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Frontotemporal dementia, wide, incl. Pick's disease
based on the number of shared cases.
Similar with more cases:
- Any dementia
- Any dementia, excluding more controls
- Dementia
- Dementia, including avohilmo
- Organic, including symptomatic, mental disorders
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 218 | 95 | 123 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | 69.55 | 70.01 | 69.20 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 187
- Matched controls
- 1868
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
134.0
112
*
G31.0
ICD-10 Finland
Circumscribed brain atrophy
1287.3
85.7
77
*
F03
ICD-10 Finland
Unspecified dementia
166.6
57.7
58
5
N05AX08
ATC
risperidone; systemic
30.7
50.2
68
34
F02.09
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
41.2
38
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
15.5
38.4
67
65
N05AH04
ATC
quetiapine; oral
11.2
37.6
80
117
N06DA02
ATC
donepezil; oral
199.0
32.9
33
*
TAB00
NOMESCO Finland
Lumbar puncture
19.8
30.7
47
31
N05AH03
ATC
olanzapine; systemic
20.0
29.6
45
29
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
11.6
28.9
57
68
N03AG01
ATC
valproic acid; systemic, rectal
17.0
28.4
46
35
XA800
NOMESCO Finland
Neuropsychological investigation
20.7
27.4
41
25
N06DX01
ATC
memantine; oral
70.9
26.9
30
5
P20
ICPC
Memory disturbance
7.6
24.9
65
122
P70
ICPC
Dementia
78.3
24.5
27
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
11.1
23.7
47
55
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
9.7
20.0
42
54
N05BA06
ATC
lorazepam; systemic, sublingual
12.5
19.7
36
35
N06DA03
ATC
rivastigmine; oral, transdermal
111.4
19.0
20
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
210.2
18.9
19
*
F06.7
ICD-10 Finland
Mild cognitive disorder
20.8
18.4
27
15
F0203, G310
ICD-10 Finland
NA
+∞
18.0
17
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
16.9
16
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
185.9
16.8
17
*
A28
ICPC
Limited function/disability NOS
4.4
15.5
65
201
F0204, G310
ICD-10 Finland
NA
+∞
14.8
14
*
F0200, G310
ICD-10 Finland
NA
+∞
13.7
13
*
N06AX11
ATC
mirtazapine; oral
3.5
13.1
80
331
N05BA04
ATC
oxazepam; oral
3.6
12.7
69
259
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
+∞
12.6
12
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
138.9
12.6
13
*
N06AB10
ATC
escitalopram; oral
4.5
12.4
47
129
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.6
11.7
35
74
F02.00
ICD-10 Finland
Dementia in Pick's disease without additional symptoms
+∞
11.6
11
*
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
+∞
11.6
11
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
37.6
11.4
14
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
30.1
10.9
14
5
N06AX16
ATC
venlafaxine; oral
4.8
10.9
38
95
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
63.7
10.8
12
*
RT250
NOMESCO Finland
NA
116.3
10.5
11
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
10.5
10
*
R41.0
ICD-10 Finland
Disorientation, unspecified
9.3
10.4
21
25
SPAT1234
SPAT
Support of social functional capacity
7.5
10.3
24
36
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.6
10.2
30
62
N05AD01
ATC
haloperidol; systemic
12.3
9.8
17
15
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
58.1
9.8
11
*
R41.3
ICD-10 Finland
Other amnesia
11.6
9.5
17
16
SPAT1216
SPAT
Assessment of functional ability
3.4
9.5
50
179
F06.4
ICD-10 Finland
Organic anxiety disorder
+∞
9.4
9
*
G30.8
ICD-10 Finland
Other Alzheimer disease
+∞
9.4
9
*
F02.04
ICD-10 Finland
Dementia in Pick's disease other additional symptoms of mixed type
+∞
9.4
9
*
F0202, G310
ICD-10 Finland
NA
+∞
9.4
9
*
AA1AD
NOMESCO Finland
CT of head and brain
2.9
9.4
73
341
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.0
9.2
25
47
SPAT1245
SPAT
Provision of support and information to patient’s family members
7.5
9.1
21
31
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
38.7
9.1
11
*
N03AX09
ATC
lamotrigine; oral
9.4
9.0
18
21
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.1
8.6
23
42
RT150
NOMESCO Finland
NA
94.1
8.5
9
*
N05CD07
ATC
temazepam; oral
3.4
8.5
43
150
F0201, G310
ICD-10 Finland
NA
+∞
8.4
8
*
P99
ICPC
Psychological disorders other
15.4
8.3
13
9
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.3
8.3
31
83
N99
ICPC
Neurological disease other
23.2
8.1
11
5
F22.0
ICD-10 Finland
Delusional disorder
15.9
7.8
12
8
N05AX12
ATC
aripiprazole; systemic
15.9
7.8
12
8
P28
ICPC
Limited function/disability (P)
47.0
7.8
9
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
19.4
7.7
11
6
A04
ICPC
Weakness/tiredness general
3.4
7.6
38
131
N06AB04
ATC
citalopram; systemic
2.8
7.4
53
231
F05.9
ICD-10 Finland
Delirium, unspecified
7.8
7.4
16
22
G30.0
ICD-10 Finland
Alzheimer disease with early onset
+∞
7.3
7
*
F064, G310
ICD-10 Finland
NA
+∞
7.3
7
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
31.3
7.2
9
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
7.5
7.2
16
23
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
10.6
7.2
13
13
R53
ICD-10 Finland
Malaise and fatigue
2.8
7.1
52
229
P29
ICPC
Psychological sympt/compl other
7.7
6.9
15
21
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
41.6
6.8
8
*
N05BA01
ATC
diazepam; systemic, rectal
3.1
6.7
38
142
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.2
6.3
8
315
F060, G310
ICD-10 Finland
NA
+∞
6.3
6
*
F020, G310
ICD-10 Finland
NA
+∞
6.3
6
*
F06.32
ICD-10 Finland
Organic depression
+∞
6.3
6
*
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
+∞
6.3
6
*
IGV01
NOMESCO Finland
Psychiatric network contact
+∞
6.3
6
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
27.7
6.3
8
*
-
ICD-10 Finland
NA
8.1
6.2
13
17
N06AX26
ATC
vortioxetine; oral
7.1
6.2
14
21
A06AD11
ATC
lactulose; oral
2.8
6.1
41
170
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
6.1
73
415
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.3
6.0
21
53
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
34
12
33.38
51.34
1.0
1.1
ng/l
39.2
29.9
—
24
5
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
33
12
32.23
49.30
1.0
1.0
ng/l
755.8
574.0
—
24
6
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
32
12
31.08
47.27
1.0
1.0
ng/l
256.8
243.4
—
23
5
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
33
34
11.26
29.29
1.1
1.2
e6/l
1.6
3.4
1.72
25
27
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
34
10.86
27.77
1.1
1.3
e6/l
120.1
100.2
0.08
24
27
(3023410) Appearance of Cerebral spinal fluid
19
13
15.92
21.32
1.4
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
94
367
3.74
19.85
2.0
1.7
nmol/l
1341.1
1203.2
0.72
73
267
(3044290) Cell count panel - Cerebral spinal fluid
24
31
8.58
17.78
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
13
9.71
9.96
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
42
4.86
8.29
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
39
4.94
8.03
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
39
4.94
8.03
1.2
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
70
357
2.42
7.91
3.0
3.3
mmol/l
2.4
2.5
1.09
54
307
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
118
757
2.22
7.67
2.8
2.0
pmol/l
87.9
95.5
1.11
66
380
(3015377) Calcium [Moles/volume] in Serum or Plasma
101
610
2.22
7.61
2.5
3.4
mmol/l
2.4
2.3
0.12
83
525
(3011397) Hemoglobin [Presence] in Urine by Test strip
71
380
2.29
7.09
4.9
3.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
40
170
2.66
6.53
2.4
2.4
u/l
35.0
35.2
0.01
35
138
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
35
139
2.81
6.50
2.7
1.7
%
1.5
1.7
1.15
30
116
(3018418) pH of Serum or Plasma
93
577
2.07
6.24
3.3
4.1
ph
7.4
7.4
0.24
12
116
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
46
215
2.44
6.17
1.8
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
45
210
2.44
6.05
1.8
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
48
231
2.38
6.03
10.7
7.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
75
460
1.96
4.99
1.8
1.6
nmol/l
20.1
20.9
0.19
67
379
(1761868) Lipid panel - Serum or Plasma
24
533
0.38
4.96
2.9
3.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
54
297
2.09
4.84
1.8
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
57
327
2.01
4.54
3.0
3.1
e6/l
1.2
1.0
0.31
29
194
(3019150) Specific gravity of Urine by Refractometry
61
359
1.97
4.52
5.2
4.5
kg/l
1.0
1.0
—
5
53
(3024561) Albumin [Mass/volume] in Serum or Plasma
110
788
1.80
4.36
4.0
4.8
g/l
35.5
35.1
0.31
96
733
(40758558) Short blood count panel - Blood
70
440
1.87
4.23
6.8
6.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
84
561
1.81
4.17
2.7
2.0
u/l
384.8
272.3
0.36
74
519
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
37
3.67
4.12
1.1
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
79
522
1.81
4.04
3.9
3.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
70
447
1.83
3.99
4.0
3.8
%
88.5
87.5
0.12
65
435
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
114
843
1.74
3.92
7.0
5.9
mmol/l
1.2
1.2
0.10
99
744
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
96
684
1.72
3.72
3.8
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
42
3.23
3.43
1.1
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
50
302
1.85
3.35
3.0
3.3
e6/l
6.6
2.5
0.60
22
172
(3028707) Methadone [Presence] in Urine by Screen method
6
7
8.77
3.28
1.5
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
80
558
1.69
3.26
4.3
3.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
32
169
2.05
3.16
5.2
8.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
118
916
1.63
3.13
7.0
6.8
mmol/l
1.2
1.2
0.57
94
758
(3030467) Casts [#/volume] in Urine by Automated count
78
550
1.65
3.01
3.9
3.3
e6/l
0.2
0.6
1.40
61
418
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
17
71
2.51
2.88
2.1
3.1
pmol/l
4.0
4.3
—
10
64
(3041096) Erythrocytes [Presence] in Urine by Automated
27
478
0.50
2.87
4.9
3.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
15
59
2.66
2.85
4.2
3.6
—
—
—
0
0
(3013512) EKG study
38
595
0.56
2.67
3.5
4.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
15
4.78
2.62
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
152
1.97
2.57
4.3
3.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
145
1656
0.63
2.56
3.9
5.0
mmol/l
1.4
1.5
0.78
123
1480
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
10
246
0.38
2.48
3.2
5.2
%
39.4
31.9
—
5
154
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
12
5.11
2.42
1.5
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
5
155
0.31
2.39
2.0
4.1
—
0.2
—
0
53
(3011288) Drugs identified in Urine by Screen method
5
8
6.36
2.38
2.6
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
42
618
0.60
2.27
3.1
4.1
mg/mmol
5.6
9.2
0.80
30
385
(3003338) MCHC [Mass/volume]
153
1317
1.54
2.23
31.6
22.2
g/l
330.3
331.5
0.83
146
1309
(3023368) Bacteria identified in Blood by Culture
73
539
1.53
2.22
4.7
4.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
210
0.40
2.21
1.0
1.3
—
—
—
0
0
(3020891) Body temperature
16
74
2.25
2.21
16.3
3.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
144
1230
1.50
2.12
5.5
3.9
pmol/l
14.2
15.0
3.28
129
1072
(3025159) Blasts/100 leukocytes in Blood
5
145
0.33
2.11
2.0
4.2
—
0.0
—
0
44
(3002179) Metamyelocytes/100 leukocytes in Blood
5
144
0.33
2.11
2.0
3.9
—
0.3
—
0
38
(3003396) Base excess in Arterial blood by calculation
37
235
1.69
2.08
9.8
6.9
mmol/l
1.1
1.0
0.05
30
189
(3016879) Cocaine [Presence] in Urine
6
15
4.08
2.05
1.5
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
15
4.08
2.05
1.7
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
139
1184
1.48
2.03
5.3
4.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
40
582
0.62
2.03
2.7
3.3
mg/l
31.5
164.3
0.65
30
377
(40768804) Tissue Pathology biopsy report
51
700
0.65
1.99
1.9
2.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
149
1666
0.67
1.99
3.9
5.1
mmol/l
4.6
4.5
0.51
126
1500
(3002582) Erythrocytes [#/volume] in Urine
78
597
1.48
1.97
3.8
3.5
e6/l
33.1
169.7
0.70
58
471
(3027944) Amphetamines [Presence] in Urine
6
16
3.82
1.95
1.7
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
16
3.82
1.95
1.5
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
16
3.82
1.95
1.7
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
143
1609
0.68
1.94
3.6
4.5
mmol/l
1.4
1.3
1.61
119
1429
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
52
0.00
1.91
0.0
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
154
1705
0.67
1.87
4.8
5.7
mmol/l
2.7
2.6
0.47
133
1528
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
110
1.90
1.80
1.8
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
62
461
1.48
1.79
3.2
2.1
mg/l
3.2
3.2
0.02
55
402
(3003694) ABO and Rh group [Type] in Blood
26
407
0.59
1.76
1.3
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
85
674
1.43
1.75
4.5
4.0
e6/l
102.6
87.8
0.11
63
506
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
30
189
1.68
1.74
3.5
2.4
ug/l
7.9
8.8
0.08
21
167
(3029937) Albumin [Presence] in Urine by Test strip
63
477
1.45
1.65
6.0
4.2
estimate
0.0
0.0
—
10
165
(3026782) Osmolality of Urine
53
388
1.48
1.64
3.1
2.9
mosm/kgh2o
528.7
542.1
0.18
48
330
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
20
3.05
1.59
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
167
0.46
1.55
1.1
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
152
1669
0.71
1.52
4.9
5.2
mmol/l
6.2
6.1
0.39
135
1497
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
55
413
1.44
1.49
1.6
1.8
pmol/l
440.0
441.9
0.02
44
333
(3012095) Magnesium [Moles/volume] in Serum or Plasma
44
320
1.47
1.41
3.0
3.3
mmol/l
0.8
0.8
0.23
37
298
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
64
798
0.72
1.40
3.6
4.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
44
584
0.69
1.38
2.6
3.2
mmol/l
7.9
7.2
0.55
39
473
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
148
1622
0.73
1.35
6.1
6.8
mmol/mol
40.0
40.9
0.53
135
1486
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
41
0.00
1.32
0.0
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
18
107
1.74
1.30
4.9
7.0
mmol/l
26.1
24.8
0.78
18
107
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
148
1618
0.73
1.28
20.0
16.0
ml/min/173m2
76.3
73.7
1.03
124
1318
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
33
0.00
1.17
0.0
2.7
—
60.6
—
0
33
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
35
0.00
1.16
0.0
2.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
35
0.00
1.16
0.0
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
65
1.90
1.16
2.3
2.4
u/ml
0.4
0.4
—
7
34
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
152
1380
1.34
1.15
6.9
7.9
u/l
82.1
80.3
0.17
134
1281
(3051611) Lipemic interference index of Serum or Plasma
5
21
2.41
1.09
5.4
2.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
113
990
1.29
1.09
5.3
3.4
u/l
60.4
54.6
0.16
101
893
(3022621) pH of Urine by Test strip
6
124
0.47
1.08
2.3
2.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
269
0.64
1.01
1.3
1.3
iu/ml
18.2
46.7
—
6
95
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
186
0.57
1.01
1.1
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
0
29
0.00
0.98
0.0
4.4
—
1.1
—
0
23
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
32
0.00
0.96
0.0
2.5
—
4.6
—
0
32
(3035350) Ketones [Presence] in Urine by Test strip
97
844
1.27
0.95
5.0
4.0
estimate
0.0
0.0
0.00
11
176
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
110
1.59
0.94
1.8
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
154
0.57
0.92
1.4
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
20
136
1.52
0.90
11.5
4.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
98
863
1.25
0.85
5.0
4.0
estimate
0.0
0.0
—
10
168
(3021601) Nitrite [Presence] in Urine by Test strip
97
854
1.24
0.84
6.0
5.4
estimate
0.0
0.0
0.00
11
176
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
12
73
1.68
0.83
2.4
2.1
g/l
42.1
36.8
—
6
63
(3019198) Lymphocytes [#/volume] in Blood
98
866
1.24
0.82
4.8
5.8
e9/l
1.7
2.0
1.22
83
757
(40768797) Stomach Pathology biopsy report
18
255
0.68
0.80
1.4
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
79
683
1.25
0.80
2.5
2.2
nmol/l
74.5
80.1
1.11
67
593
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
12
74
1.66
0.80
2.4
2.4
g/l
1.3
0.6
—
7
65
(4146454)
0
24
0.00
0.79
0.0
3.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
24
0.00
0.79
0.0
1.1
—
6.3
—
0
9
(40768806) Pleura Pathology biopsy report
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
164
1539
1.26
0.76
6.5
4.7
mu/l
2.7
2.0
0.59
143
1349
(3026493) Urate [Moles/volume] in Serum or Plasma
40
493
0.77
0.76
2.2
2.9
umol/l
351.1
7718.7
2.21
27
403
(3042936) Bacteria identified in Isolate by Culture
20
274
0.70
0.75
2.0
1.9
—
—
—
0
0
(4034850)
9
55
1.66
0.74
9.2
11.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
99
883
1.22
0.74
6.2
5.8
e9/l
0.2
0.2
0.22
83
765
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
176
1668
1.29
0.73
20.8
16.4
mg/l
32.9
25.6
1.38
136
1341
(3013650) Neutrophils [#/volume] in Blood by Automated count
111
1003
1.22
0.72
8.7
9.3
e9/l
4.7
4.2
1.01
92
868
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
57
1.60
0.72
1.0
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
26
197
1.36
0.70
1.8
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
152
1421
1.23
0.69
26.4
17.8
%
39.7
39.3
0.28
99
911
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
44
361
1.27
0.69
4.2
3.7
ng/l
56.5
222.0
2.21
39
309
(3001604) Monocytes [#/volume] in Blood
95
849
1.21
0.68
4.8
5.6
e9/l
0.6
0.6
0.49
77
720
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
95
0.52
0.68
1.2
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
86
762
1.21
0.67
4.2
4.2
ng/l
67.3
44.5
0.23
63
594
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
18
245
0.71
0.66
1.4
1.3
u/ml
1.8
14.7
—
7
92
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
138
1.41
0.65
1.3
1.4
—
—
—
0
0
(3012544) pH of Venous blood
25
191
1.35
0.64
2.2
4.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
20
147
1.40
0.64
3.1
3.6
ng/l
85.2
86.9
0.04
13
129
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
29
1.74
0.64
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
49
1.66
0.63
1.0
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
95
856
1.19
0.61
4.9
5.6
e9/l
0.0
0.0
0.08
80
728
(3044927) Protein electrophoresis panel - Urine
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
20
0.00
0.60
0.0
2.4
—
573.5
—
0
11
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
20
0.00
0.60
0.0
1.1
—
7.2
—
0
13
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
97
1.47
0.60
2.4
2.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
21
0.00
0.60
0.0
3.6
—
61.2
—
0
12
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
22
0.00
0.59
0.0
5.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
26
203
1.32
0.59
2.0
3.3
umol/l
8.0
9.5
0.21
21
180
(3045424) Erythrocytes [Presence] in Urine
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
23
0.00
0.58
0.0
3.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
171
1783
0.81
0.58
23.6
20.1
umol/l
75.9
82.7
3.19
171
1783
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
86
774
1.18
0.56
2.8
2.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
82
1.49
0.55
2.4
2.0
g/l
2.9
3.3
—
7
66
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
206
1.30
0.54
3.6
3.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
29
234
1.28
0.53
1.8
3.0
%
1.6
1.7
0.37
24
208
(3019225) pH of Specimen
13
178
0.71
0.51
3.9
3.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
70
780
0.85
0.50
5.0
5.5
ug/l
2.7
2.8
0.05
58
685
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
84
1.45
0.50
2.4
1.9
g/l
8.5
10.6
—
6
74
(3024928) Oxygen saturation in Venous blood
7
45
1.57
0.49
1.3
3.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
164
1.31
0.49
1.1
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
47
1.51
0.48
2.6
3.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
106
980
1.16
0.48
4.7
6.5
umol/l
10.5
11.7
0.83
95
926
(42870588) Differential panel, method unspecified - Blood
65
579
1.17
0.47
4.8
5.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
16
122
1.34
0.43
27.9
6.6
mmol/l
25.4
24.5
0.52
16
116
(3007164) IgA [Mass/volume] in Serum or Plasma
25
303
0.80
0.43
1.6
1.4
g/l
2.3
2.5
0.32
13
177
(42529406) Shigella sp [Presence] in Stool by Culture
8
57
1.42
0.42
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
57
1.42
0.42
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
57
1.42
0.42
1.4
1.2
—
—
—
0
0
(4010399)
11
149
0.72
0.41
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(4268621)
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
17
0.00
0.41
0.0
1.1
—
37323.6
—
0
11
(3011412) CD3 cells [#/volume] in Blood
0
17
0.00
0.41
0.0
2.0
—
0.8
—
0
7
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.6
—
14.2
—
0
17
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
18
0.00
0.40
0.0
1.7
—
310.3
—
0
18
(4306422)
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
1.4
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
37
1.36
0.37
1.2
2.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
90
1.35
0.36
2.4
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
90
1.35
0.36
2.4
2.0
g/l
4.9
3.8
—
7
65
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
90
1.35
0.36
2.4
2.0
g/l
7.2
7.7
—
7
67
(40761536) Microorganisms panel - Urine sediment
12
156
0.76
0.36
6.7
3.9
—
—
—
0
0
(3002256) Pathology report gross observation
19
232
0.80
0.36
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
72
664
1.13
0.32
5.6
4.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
37
326
1.16
0.31
1.5
2.4
umol/l
11.4
13.0
0.79
30
298
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
100
0.69
0.31
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
55
1.28
0.30
1.4
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
32
364
0.86
0.30
2.1
5.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
106
0.75
0.29
2.9
8.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
56
1.26
0.29
1.7
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
174
1785
0.88
0.29
11.8
11.6
u/l
23.2
24.7
0.76
161
1701
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
63
681
0.89
0.28
2.7
3.1
ng/l
796.3
1574.8
2.40
56
583
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
40
445
0.88
0.28
2.4
3.2
ug/l
0.9
0.8
0.09
32
309
(3001122) Ferritin [Mass/volume] in Serum or Plasma
71
660
1.11
0.27
3.3
2.7
ug/l
89.6
155.0
3.69
61
600
(3000492) Spirometry study
12
149
0.79
0.26
1.3
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
212
0.84
0.25
1.3
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
34
304
1.14
0.24
1.4
2.4
g/l
2.3
2.3
0.34
26
281
(36660697) Celiac disease serology panel - Serum
8
105
0.75
0.21
1.3
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.5
—
1.6
—
0
6
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.5
—
59.3
—
0
6
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
10
0.00
0.21
0.0
1.2
—
5443.4
—
0
5
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
0
10
0.00
0.21
0.0
2.3
—
13.8
—
0
5
(3018010) Neutrophils/100 leukocytes in Blood
84
797
1.09
0.21
5.0
5.8
%
60.1
58.1
0.73
76
738
(3004588) Protein electrophoresis panel - Serum or Plasma
17
145
1.19
0.21
2.1
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
78
823
0.92
0.21
5.6
10.2
inr
1.1
1.3
3.36
14
248
(3014271) Vancomycin [Susceptibility]
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.4
—
0.1
—
0
8
(3032773) Endomysium IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.4
—
14.2
—
0
14
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
14
0.00
0.20
0.0
1.4
—
31478.5
—
0
8
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.7
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.7
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
129
1249
1.08
0.19
3.8
4.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
140
1360
1.08
0.19
26.8
20.8
%
14.0
13.9
0.20
132
1335
(3015235) Bicarbonate [Moles/volume] in Capillary blood
6
53
1.14
0.19
2.8
2.3
mmol/l
25.1
25.3
—
6
42
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
45
417
1.10
0.19
2.2
2.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
61
1.15
0.17
1.7
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
66
0.75
0.17
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
70
1.15
0.16
1.9
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
111
1074
1.07
0.16
7.8
4.8
mmol/l
7.1
6.9
0.43
98
1008
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
140
0.85
0.15
1.3
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
79
1.15
0.15
1.2
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
42
392
1.09
0.15
1.7
1.7
mg/l
1.5
1.5
0.03
31
308
(3035941) MCH [Entitic mass]
180
1827
0.92
0.15
31.0
24.0
pg
30.4
30.5
0.11
172
1794
(3010813) Leukocytes [#/volume] in Blood
180
1827
0.92
0.15
31.1
24.1
e9/l
7.0
6.8
0.66
171
1758
(3026361) Erythrocytes [#/volume] in Blood
180
1827
0.92
0.15
31.1
24.1
e12/l
4.3
4.4
3.07
171
1760
(3000963) Hemoglobin [Mass/volume] in Blood
180
1827
0.92
0.15
31.2
24.2
g/l
130.7
134.5
2.57
172
1791
(3024731) MCV [Entitic volume]
180
1827
0.92
0.15
31.0
24.0
fl
91.9
91.7
0.26
172
1794
(3044640) Blood type and Crossmatch panel - Blood
53
560
0.93
0.14
2.5
2.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
181
1783
1.09
0.14
27.1
19.5
mmol/l
139.7
139.7
0.05
171
1733
(3007461) Platelets [#/volume] in Blood
180
1826
0.92
0.14
31.1
24.1
e9/l
246.7
241.6
0.42
171
1768
(3049717) Cytology report of Urine Cyto stain
8
98
0.81
0.14
2.6
3.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
84
811
1.06
0.12
5.0
6.1
%
25.1
26.3
0.44
74
743
(3022096) Basophils/100 leukocytes in Blood
80
773
1.06
0.11
5.2
5.8
%
0.7
0.6
0.27
71
714
(3023103) Potassium [Moles/volume] in Serum or Plasma
181
1788
1.07
0.11
26.1
19.7
mmol/l
4.0
4.0
1.08
171
1740
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
146
0.88
0.11
1.3
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
5
48
1.04
0.09
3.2
2.1
kpa
8.0
8.0
—
5
42
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
146
1.10
0.08
2.2
3.1
ml/min/173m2
80.2
60.5
—
5
66
(40761511) CBC panel - Blood by Automated count
174
1723
1.05
0.07
17.9
15.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
18
168
1.08
0.06
2.1
2.7
g/l
67.2
66.6
0.13
11
153
(3006504) Eosinophils/100 leukocytes in Blood
81
794
1.03
0.05
5.1
5.8
%
2.8
2.7
0.10
72
731
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
61
623
0.97
0.04
4.4
4.8
%
20.9
21.7
0.13
23
324
(3019069) Monocytes/100 leukocytes in Blood
81
799
1.02
0.03
5.2
6.1
%
8.7
8.9
0.27
71
742
(3021589) Normoblasts [#/volume] in Blood
80
792
1.02
0.01
8.4
10.7
e9/l
0.0
0.0
0.58
61
647
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
58
574
1.01
0.00
2.9
2.4
u/l
48.4
58.5
1.94
52
523
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
336
1.01
0.00
1.4
1.2
u/ml
0.7
1.5
—
9
87
(3013707) Erythrocyte sedimentation rate by Westergren method
127
1271
1.00
0.00
3.1
4.4
mm/h
13.5
14.4
0.26
112
1151
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
96
1.04
0.00
4.7
2.8
%
1.2
1.0
—
10
96
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
16
162
0.99
0.00
1.7
2.8
ng/l
146.9
228.3
0.73
16
143
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
84.0
—
0
7
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
0.9
—
0
7
(3025941) Bacteria identified in Stool by Culture
9
92
0.98
0.00
1.4
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
719.8
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
40.0
—
0
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.3
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
17.3
—
0
6
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
5
54
0.92
0.00
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
2.1
—
94.5
—
0
8
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
57
0.87
0.00
1.8
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.1
—
8.9
—
0
9
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
11.1
—
0
6
(40768800) Prostate Pathology biopsy report
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.8
—
212.5
—
0
8
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
5.9
—
45.8
—
0
8
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
1473.0
—
0
5
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
-0.00
0.0
1.0
—
145.4
—
0
5
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
5
0.00
-0.00
0.0
2.6
—
84.2
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
11.7
—
0
5
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: FTD_WIDE – Frontotemporal dementia, wide, incl. Pick's disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).